
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3155237610.1021/acsomega.9b02430ArticleSynthetic Strategy for Pyrazolo[1,5-a]pyridine
and Pyrido[1,2-b]indazole
Derivatives through AcOH and O2-Promoted Cross-dehydrogenative
Coupling Reactions between 1,3-Dicarbonyl Compounds and N-Amino-2-iminopyridines Behbehani Haider *†Ibrahim Hamada Mohamed *†‡† Chemistry
Department, Faculty of Science, Kuwait University, P.O. Box 5969, Safat 13060, Kuwait‡ Chemistry
Department, Faculty of Science, Fayoum University, P.O. Box 63514, Fayoum, Egypt* E-mail: drhaider.b@gmail.com. Tel.: +965-55888646. Fax: +965-248-164-82 (H.B.).* E-mail: hmi00@fayoum.edu.eg and drhamadaibrahim@yahoo.com. Tel.: +965-55216585. Fax: +965-248-164-82 (H.M.I).04 09 2019 17 09 2019 4 12 15289 15303 31 07 2019 21 08 2019 Copyright © 2019 American Chemical
Society2019American Chemical
SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

An efficient method has been developed
for the synthesis of uniquely
substituted pyrazolo[1,5-a]pyridine and pyrido[1,2-b]indazole derivatives, which involves acetic acid and molecular
oxygen promoted cross-dehydrogenative coupling reactions of respective
β-ketoesters and β-diketones (like ethyl acetoacetate,
ethyl benzoylacetate, methyl propionylacetate, acetylacetone, dimedone,
1,3-cyclohexanedione, and 1,3-cyclopentanedione) with N-amino-2-iminopyridines. The proposed tentative mechanism involves
formal acetic acid-promoted oxidative C(sp3)–C(sp2) dehydrogenative coupling followed by dehydrative cyclization
under a catalyst-free condition within high atom economy processes.

document-id-old-9ao9b02430document-id-new-14ao-2019-02430mccc-price
==== Body
Introduction
Fused nitrogen containing
heterocyclic ring systems is a key structural
motif in many natural products and pharmaceutically active compounds.1−3 As a result, these ring systems are often considered as important
backbones in the design of new drugs. Among fused N-heteroaromatic substances, those containing pyrazolo[1,5-a]pyridine and pyrido[1,2-b]indazole ring
systems are medicinally important owing to their anti-viral,4 -cancer,5 -inflammatory,6 -fungal,7 and -tubercular
activities.8,9 Moreover, the pyrazolopyridine ring system
is present in the known dopamine D3 agonist and D4 antagonist shown
in Figure 1.5 Consequently, drugs containing this structural
framework have been developed for the treatment of many neurological
and central nervous system disorders like Parkinson’s disease,
schizophrenia, anxiety, unipolar major depression, and attention deficit
disorder.10−12 In addition, substituted pyrazolo[1,5-a]pyridines and pyrido[1,2-b]indazoles have been
observed to have potent antiherpetic13 and
diuretic activities (Figure 1).14 Finally, several pyrazolo[1,5-a]pyridine derivatives are known to be selective p38 inhibitors.15

Figure 1 Examples of biologically active pyrazolo[1,5-a]pyridines and pyrido[1,2-b]indazoles.

The elegant conceptual basis for and applications of cross-dehydrogenative
coupling (CDC) reactions has greatly expanded in recent years. As
a result, great progress has been made in developing new approaches
for forming different types of bonds that are difficult to construct
by using older classical methods.16−25 The CDC concept has been employed to devise new strategies to construct
an assortment of bonds as part of sequences to generate complex organic
substances. An important example is C–C bond formation, which
can be carried out using intramolecular26−29 or intermolecular30−39 CDC reactions between two C–H bond bearing moieties. In addition,
CDC reactions have been developed for C–O,40,41 C–N,42−46 S–N,47,48 C–S,49,50 S-P,51 and C–P52,53 bond formation.

In comparison with their traditional cross-coupling
counterparts,
cross-dehydrogenative coupling reactions are sustainable owing to
their green characteristics, including atom efficiency, step economy,
and lack of prefunctionalization.54,55 C(sp2)–H–C(sp3)–H cross-dehydrogenative
coupling reactions are now among the most important methods for construction
of C–C bonds in a single step. However, the methods developed
for CDC to date usually require a catalyst to activate feebly reactive
C(sp3)–H bonds. The catalysts typically used for
this purpose include complexes of transition metals, like copper (Cu),56 palladium (Pd),57 gold (Au),58 ruthenium (Ru),23,59 iron (Fe),60 iridium (Ir),,61 vanadium (V),62 and
cobalt (Co).63 In addition, some of the
CDC processes are activated by nonmetal catalysts, such as iodine,50,64 rose bengal,65 1,4-benzoquinone,66 phenyliodonium diacetate,67 and eosin.68

In a continuation
of efforts aimed at developing methods for the
synthesis of novel fused N-heterocycles,69−74 our recent attention became focused on members of the pharmaceutically
relevant pyrazolo[1,5-a]pyridine and pyrido[1,2-b]indazole families. Particular attention was given to devising
novel aerobic, catalyst-free CDC processes that would produce these
targets in an efficient and atom economical manner. The investigation
described below demonstrates that simple cross-dehydrogenative coupling
reactions of N-amino-2-iminopyridine derivatives
with β-ketoesters and β-diketones, promoted by utilizing
the green oxidant molecular oxygen (O2) and the mild reagent
acetic acid, efficiently generate respective pyrazolo[1,5-a]pyridines and pyrido[1,2-b]indazoles.

Results
and Discussion
The most commonly utilized synthetic protocol
to prepare pyrazolo[1,5-a]pyridines involves intermolecular
[3 + 2] cycloaddition
of N-iminopyridinium ylides with alkenes or alkynes
as dipolarophiles (Scheme 1a).75 Also, synthesis of these
substances has been accomplished via intramolecular cyclizations of
transient nitrenes15b,76 and ethynylpyridines.77,78 We envisaged that a novel and potentially more simple strategy for
synthesis of substituted pyrazolo[1,5-a]pyridines
and related pyrido[1,2-b]indazoles would involve
cross-dehydrogenative coupling reactions between N-amino-2-iminopyridine derivatives and β-ketoesters and β-diketones
(Scheme 1b).

Scheme 1 Previous
(a) and Newly Developed (b) Routes for the Synthesis of
Substituted Pyrazolo[1,5-a]pyridines
In an initial study designed to assess the viability of
this approach,
we explored the CDC reaction between N-aminopyridine 1a and ethyl acetoacetate (2a). We observed that
the reaction of 1-amino-2-imino-4-phenyl-1,2-dihydropyridine-3-carbonitrile
(1a) (3 mmol) and 2a (3 mmol) in refluxing
ethanol (10 mL) under an air atmosphere for up to 48 h leads to quantitative
recovery of the starting materials. Also, no reaction takes place
between 1a with 2a under the same conditions
when either Pd(OAc)2 (10 mol %) or Cu(OAc)2 is
present. A screening effort showed that no reaction occurs between 1a and 2a when various other solvents, including
acetonitrile, methanol, dioxane, propanol, H2O, and toluene,
are employed. Interestingly, when acetic acid or DMF is used as solvent
and Pd(OAc)2 (10 mol %) is employed as catalyst, reactions
do take place to form the respective triazolo[1,5-a]pyridine derivatives 3a (72%) and 3b (74%).
These substances presumably arise by reaction of the N-amino-2-iminopyridine 1a with either acetic acid or
DMF, Scheme 2.

Scheme 2 Reactions of N-aminopyridine 1a and
Ethyl acetoacetate (2a) in HOAc and DMF in the Presence
of Pd(OAc)2 To Form Triazolo[1,5-a]pyridines 3a and 3b, Respectively
Rewardingly, when acetic acid (0.36 g, 2 equiv) is present, the
reaction of 1a and 2a in ethanol under an
air atmosphere does take place to form the desired 7-amino-6-cyano-2-methyl-5-phenylpyrazolo[1,5-a]pyridine-3-carboxylic acid ethyl ester (4a, 34%) (Table 1) (Table 1, entry 1). The structure
of 4a was assigned using spectroscopic methods and comparisons
of the data to those of related substances that are characterized
by using X-ray crystallographic analysis (see below). For example,
the 1H NMR spectrum of 4a contains resonances
corresponding to ethyl (1.32 ppm, t) and (4.30 ppm, q), CH3 (2.62 ppm, s), H-5 pyridine (7.20 ppm, s), NH2 (7.76 ppm, s), and phenyl [7.48–7.54 (3H, m) and 7.58–7.59
(2H, m)] moieties. Moreover, as anticipated for 4a, the 13C NMR spectrum contains 16 characteristic resonances and
the HRMS contains a mass peak at m/z 320.1268 associated with the molecular formula C18H16N4O2.

Table 1 Reaction
of N-aminopyridine 1a and Ethyl acetoacetate
(2a) in Ethanol Containing
Acetic Acid To Form Pyrazolo[1,5-a]pyridine 4aa
entry	molar equiv.
acid	atmosphere	percent yield 4a	
1	(HOAc) 2	air	34	
2	(HOAc) 4	air	52	
3	(HOAc) 6	air	74	
4	(HOAc) 6	O2	94	
5	(HOAc) 6	Ar	6	
6	(p-TSA) 1	O2	39	
7	(p-TSA) 2	O2	41	
8	(TFA) 1	O2	48	
9	(TFA) 2	O2	55	
a Reaction conditions: N-amino-2-imino-pyridine 1a (3 mmol), ethyl
acetoacetate
(2a) (3 mmol), in ethanol (10 mL), under an atmosphere
of air or O2 1 atm at 130 °C for 18 h.

Experiments were conducted to determine
the effect of acetic acid
loading on the efficiency of the 4a forming reaction
of 1a and 2a under an air atmosphere. The
results (Table 1, entries
2 and 3) show that increasing the loading of acetic acid from 2 to
4 to 6 equivalents leads to increases in the yield of 4a from 34 to 52 to 74%, respectively. Moreover, using higher amounts
of acetic acid (e. g., 8 equivalent) causes the process to become
complicated by competitive formation of triazolo[1,5-a]pyridine derivatives 3a. As a result, the maximum loading
of acetic acid was maintained at 6 equivalents to prevent the formation
of the undesired by-product (compound 3a). Importantly,
the reaction between 1a and 2a carried out
under molecular oxygen rather than an air atmosphere (1 atm) takes
place to form 4a in near quantitative yield (94%, Table 1, entry 4). As expected,
the yield of this process is significantly diminished (6%, Table 1, entry 5) when an
Ar atmosphere is utilized. This implies that the reaction is mostly
driven by oxygen, thus confirming the proposed oxidative CDC route.
Furthermore, utilizing a catalytic amount of strong Brønsted
acids like p-toluenesulfonic acid (p-TSA) or trifluoroacetic acid (TFA) was found to be less effective
under the optimal condition (Table 1, entries 6–9). It is worth mentioning that
increasing the loading of TFA above 2 equivalents leads also to a
side reaction between TFA and N-aminopyridine 1a.

A study of the CDC reaction was conducted to explore
its substrate
scope. For this purpose, an assortment of N-amino-2-iminopyridines,
including 1a–f, and β-dicarbonyl compounds,
including ethyl acetoacetate (2a), ethyl benzoylacetate
(2b), methyl propionylacetate (2c), and
acetylacetone (2d) were subjected to the optimal reaction
conditions uncovered in the exploratory investigation (entry 4, Table 1). The results (Table 2) show that reactions
between 1a–f and 2a–d generate the corresponding pyrazolo[1,5-a]pyridines 4a–v and that the presence
of either electron-withdrawing or electron-donating substituents on
the aryl moiety in the N-amino-2-iminopyridine substrate
does not have a remarkable effect on the course of the CDC process.
In addition, because of their crystalline nature, 4i and 4r were subjected to X-ray crystallographic analysis, the
results of which confirm their assigned structures (cf. Figures 2 and 3).

Figure 2 Plot of X-ray crystallographic data for 4i.

Figure 3 Plot of X-ray crystallographic data for 4r.

Table 2 Acetic Acid-Promoted CDC Reactions
of N-Amino-2-iminopyridines 1a–f and β-Ketoesters/β-Diketones 2a–da
a Reaction conditions: N-amino-2-iminopyridine 1a–f (3 mmol),
β-ketoesters/β-diketones 2a–d (3 mmol), in ethanol (10 mL) containing acetic acid (6 equiv),
under an O2 atmosphere (1 atm) at 130 °C for 18 h.

The results of further studies
demonstrated that the CDC reaction
also occurs when cyclic 1,3-diketones are utilized as substrates.
For example, the reaction of N-amino-2-iminopyridine 1a and 5,5-dimethylcyclohexane-1,3-dione (dimedone, 5a) under the optimized reaction conditions described above
produces 7-aminotetrahydropyrido[1,2-b]indazole-8-carbonitrile
(6a) in 83% yield. The structure of 6a was
unambiguously assigned using spectrometric and X-ray crystallographic
analysis (Figure 4).
Moreover, tetrahydropyrido[1,2-b]indazoles 6b–e are efficiently formed (79–87%)
in reactions of the respective N-aminopyridines 1b and 1d–f with dimedone
(5a), and analogous CDC reactions take place between
1,3-cyclohexanedione (5b) and N-amino-2-iminopyridines 1a, 1d, 1e, and 1f to form the corresponding
tetrahydropyrido[1,2-b]indazoles 6f–j in high yields (80–90%) (Table 3). The structures of two of these products, 6c and 6d, were assigned using X-ray crystallographic
methods (Figures 5 and 6). Finally, N-amino-2-iminopyridines 1a and 1b react with 1,3-cyclopentanedione 7 and 3-oxo-3-phenylpropionitrile 9 under CDC
reaction conditions to form the corresponding 2,3-dihydrocyclopenta[3,4]pyrazolo[1,5-a]pyridin-1-ones 8a and 8b (72
and 74% respective yields) and pyrazolo[1,5-a]pyridine-3,6-dicarbonitrile 10 (Scheme 3). Although the preparation of tetrahydropyrido[1,2-b]indazoles has been reported previously,79 to the best of our knowledge, the CDC process developed in the current
effort is the first to generate these substances in a direct (single
step), versatile (large substrate scope), and environmentally friendly
manner.

Figure 4 Plot of X-ray crystallographic data for 6a.

Figure 5 Plot of X-ray crystallographic data for 6c.

Figure 6 Plot of X-ray crystallographic data for 6d.

Scheme 3 CDC Reactions of N-amino-2-iminopyridines 1a and 1b with 1,3-Cyclopentanedione (7) and 3-Oxo-3-phenylpropionitrile 9
Table 3 CDC Reaction of N-amino-2-iminopyridines 1a–f with
Cyclic β-Diketones 5a,ba
a Reaction conditions: N-amino-2-iminopyridine 1a–f (3 mmol),
cyclic β-diketones 5a,b (3 mmol), in ethanol (10
mL) containing acetic acid (6 equiv), under an O2 atmosphere
(1 atm) at 130 °C for 18 h.

A plausible mechanistic pathway for the CDC coupling reactions80 described above is illustrated in Scheme 4. In one possible route, proton
transfer from acetic acid activates N-amino-2-iminopyridine 1 for nucleophilic addition of the enol form of the β-dicarbonyl
substrates 2 or 5. The resulting adduct A then undergoes oxidative dehydrogenation via a reaction
with molecular oxygen to form intermediate B, which cyclizes
to generate C that loses water to produce the pyrazolo[1,5-a]pyridine 4 or pyrido[1,2-b]indazole 6 product. In an alternative mechanistic route,
dehydration/cyclization of A precedes oxidative dehydrogenation.

Scheme 4 Plausible Mechanistic Pathway for the Formation of Pyrazolo[1,5-a]pyridines 4 and Pyrido[1,2-b]indazoles 6
Conclusions
In summary, the investigation described above led to the development
of a unique CDC reaction between N-amino-2-iminopyridines
derivatives and 1,3-dicarbonyl compounds. The process, which takes
place under mild environmentally compatible conditions, is promoted
by the Bronstead acid catalyst AcOH and uses O2 as the
oxidant. Significantly, the new CDC reaction exhibits many features
required for classification as a green process, including high atom
economy, superior substrates scope, lack of toxic or harsh reagents,
and simple purification and work-up procedures. Owing to the frequent
occurrence of pyrazolo[1,5-a]pyridine and pyrido[1,2-b]indazole ring systems in drugs, the new methodology could
have significance in the context of developing new pharmaceutically
active substances.

Experimental Section
General
Melting
points were recorded on a Griffin melting
point apparatus and are uncorrected. IR spectra were recorded using
KBr disks using a Jasco FT-IR-6300 spectrophotometer. 1H NMR (600 MHz) and 13C NMR (150 MHz) spectra were recorded
at 25 °C using dimethyl sulfoxide (DMSO)-d6 as solvent with TMS as an internal standard on a Bruker DPX
600 superconducting NMR spectrometer. Chemical shifts are reported
in ppm. Low-resolution electron impact mass spectra [MS (EI)] and
high-resolution electron impact mass spectra [HRMS (EI)] were performed
using a high-resolution gas chromatography-MS (DFS) thermo-spectrometer
at 70.1 eV and a magnetic sector mass analyzer. Monitoring reactions
and checking the homogeneity of compounds were performed using thin
layer chromatography. X-ray crystal structures were determined using
a Rigaku R-AXIS RAPID diffractometer and Bruker X8 Prospector, and
the collection of single crystal data was made at room temperature
by using Cu Kα radiation. The structures were solved by using
direct methods and expanded using Fourier techniques. The nonhydrogen
atoms were refined anisotropically. The structures were solved and
refined using the Bruker SHELXTL Software Package (Structure solution
program- SHELXS-97 and Refinement program- SHELXL-97).81 Data were corrected for the absorption effects
using the multiscan method (SADABS). N-amino-2-iminopyridines 1a–f were prepared according to the literature
procedure.75d,82

2-Methyl-7-phenyl[1,2,4]triazolo[1,5-a]pyridine-8-carbonitrile
(3a)
Recrystallized from EtOH/dioxane mixture
(5:1), as yellow white crystals, yield: 0.51 g (74%), mp 155–156
°C; IR (KBr): ν/cm–1 2218 (CN); 1H NMR (600 MHz, DMSO-d6): δ
2.55 (s, 3H), 7.37 (d, J = 6.8 Hz, 1H), 7.59–7.63
(m, 3H), 7.75 (d, J = 8.4 Hz, 2H), 9.19 (d, J = 6.8 Hz, 1H); 13C{1H} NMR (150
MHz, DMSO-d6): δ 14.1, 96.4, 114.6,
114.6, 128.8, 129.0, 130.2, 132.5, 135.5, 149.1, 150.3, 165.0; MS
(EI): m/z (%) 235 (M+ + 1, 26.78), 234 (M+, 100). HRMS (EI): m/z calcd. for C14H10N4 (M+) 234.0899, found 234.0898.

7-Phenyl[1,2,4]triazolo[1,5-a]pyridine-8-carbonitrile
(3b)
Recrystallized from EtOH/dioxane mixture
(4:1), as yellow crystals, yield: 0.47 g (72%), mp 159–160
°C; IR (KBr): ν/cm–1 2221 (CN); 1H NMR (600 MHz, DMSO-d6): δ
7.49 (d, J = 7.2 Hz, 1H), 7.62–7.67 (m, 3H),
7.79 (d, J = 8.4 Hz, 2H), 8.75 (s, 1H), 9.35 (d, J = 7.2 Hz, 1H); 13C{1H} NMR (150
MHz, DMSO-d6): δ 97.6, 114.4, 115.6,
128.9, 129.0, 130.3, 133.3, 135.4, 149.6, 149.7, 155.4; MS (EI): m/z (%) 221 (M+ + 1, 17.65),
220 (M+, 100). HRMS (EI): m/z calcd. for C13H8N4 (M+) 220.0743, found 220.0743.

General Procedure for the
Preparation of Pyrazolo[1,5-a]pyridines 4a–v, 10, Pyrido[1,2-b]indazoles
6a–i and Cyclopenta[3,4]pyrazolo[1,5-a]pyridin-1-one 8a,b
Independent solutions
of 1-amino-2-imino-pyridines 1a–f (3 mmol), and the 1,3-dicarbonyl compounds 2a–d, 5a,b, 7, or 3-oxo-3-phenylpropionitrile 9 (3 mmol), in ethanol (10 mL) containing acetic acid (1.08
g, 6 equiv) under an O2 atmosphere (1 atm) were stirred
at 130 °C for 18 h. Crystals formed upon cooling to room temperature
were collected by filtration and recrystallized from an appropriate
solvent to give pure pyrazolo[1,5-a]pyridines 4a–v, 10, pyrido[1,2-b]indazoles 6a–i, and cyclopenta[3,4]pyrazolo[1,5-a]pyridin-1-one 8a,b.

7-Amino-6-cyano-2-methyl-5-phenylpyrazolo[1,5-a]pyridine-3-carboxylic acid ethyl ester (4a)
Recrystallized from EtOH as yellow white crystals, yield:
0.90 g
(94%), mp 228–229 °C; IR (KBr): ν/cm–1 3454, 3325 (NH2), 2216 (CN), 1701 (CO); 1H
NMR (600 MHz, DMSO-d6): δ 1.32 (t, J = 7.2 Hz, 3H), 2.62 (s, 3H), 4.30 (q, J = 7.2 Hz, 2H), 7.20 (s, 1H), 7.48–7.54 (m, 3H), 7.58–7.59
(m, 2H), 7.76 (s, 2H); 13C{1H} NMR (150 MHz,
DMSO-d6): δ 13.6, 13.7, 59.0, 75.4,
102.0, 103.8, 115.7, 127.8, 128.1, 128.5, 137.2, 141.9, 142.6, 147.4,
155.5, 162.4; MS (EI): m/z (%) 321
(M+ + 1, 18.95), 320 (M+, 100). HRMS (EI): m/z calcd. for C18H16N4O2 (M+) 320.1268, found 320.1268.

7-Amino-6-cyano-2-methyl-5-p-tolylpyrazolo[1,5-a]pyridine-3-carboxylic acid ethyl ester (4b)
Recrystallized from EtOH as yellow white crystals, yield:
0.95 g (95%), mp 214–215 °C; IR (KBr): ν/cm–1 3462, 3323 (NH2), 2216 (CN), 1703 (CO); 1H NMR (600 MHz, DMSO-d6): δ
1.29 (t, J = 7.2 Hz, 3H), 2.38 (s, 3H), 258 (s, 3H),
4.25 (q, J = 7.2 Hz, 2H), 7.11 (s, 1H), 7.32 (d, J = 8.4 Hz, 2H), 7.45 (d, J = 8.4 Hz, 2H),
8.11 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 14.2, 14.3, 20.8, 59.5, 75.3, 102.0,
103.6, 116.6, 128.2, 129.2, 134.7, 138.7, 142.3, 143.2, 147.9, 155.9,
162.9; MS (EI): m/z (%) 335 (M+ + 1, 22.08), 334 (M+, 100). HRMS (EI): m/z calcd. for C19H18N4O2 (M+) 334.1424, found 334.1423.

7-Amino-6-cyano-5-(4-methoxyphenyl)-2-methylpyrazolo[1,5-a]pyridine-3-carboxylic acid ethyl ester (4c)
Recrystallized from EtOH as yellow white crystals, yield:
0.92 g (88%), mp 215–216 °C; IR (KBr): ν/cm–1 3462, 3313 (NH2), 2218 (CN), 1699 (CO); 1H NMR (600 MHz, DMSO-d6): δ
1.30 (t, J = 7.2 Hz, 3H), 2.58 (s, 3H), 3.84 (s,
3H), 4.26 (q, J = 7.2 Hz, 2H), 7.08 (d, J = 8.4 Hz, 2H), 7.10 (s, 1H), 7.53 (d, J = 8.4 Hz,
2H), 8.10 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 14.2, 14.3, 55.3, 59.5, 75.4, 101.8,
103.4, 114.0, 116.7, 129.67, 129.70, 142.3, 142.9, 147.8, 155.8, 159.9,
162.9; MS (EI): m/z (%) 351 (M+ + 1, 22.25), 350 (M+, 100). HRMS (EI): m/z calcd. for C19H18N4O3 (M+) 350.1373, found 350.1373.

7-Amino-5-(4-chlorophenyl)-6-cyano-2-methylpyrazolo[1,5-a]pyridine-3-carboxylic acid ethyl ester (4d)
Recrystallized from EtOH as yellow white crystals, yield:
0.96 g (90%), mp 245–246 °C; IR (KBr): ν/cm–1 3456, 3317 (NH2), 2216 (CN), 1709 (CO); 1H NMR (600 MHz, DMSO-d6): δ
1.29 (t, J = 7.2 Hz, 3H), 2.59 (s, 3H), 4.26 (q, J = 7.2 Hz, 2H), 7.12 (s, 1H), 7.60 (s, 4H), 8.22 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 14.25, 14.28, 59.6, 75.1, 102.3, 103.8, 116.4,
128.7, 130.2, 134.0, 136.4, 141.9, 142.2, 147.9, 155.9, 162.9; MS
(EI): m/z (%) 356 (M+ + 2, 33.12), 355 (M+ + 1, 20.05), 354 (M+,
100). HRMS (EI): m/z calcd. for
C18H15ClN4O2 (M+) 354.0878, found 354.0878.

7-Amino-5-(4-bromophenyl)-6-cyano-2-methylpyrazolo[1,5-a]pyridine-3-carboxylic acid ethyl ester (4e)
Recrystallized from EtOH/dioxane mixture (3:1), as yellow
white crystals, yield: 1.00 g (84%), mp 246–247 °C; IR
(KBr): ν/cm–1 3448, 3325 (NH2),
2214 (CN), 1720 (CO); 1H NMR (600 MHz, DMSO-d6): δ 1.30 (t, J = 7.2 Hz, 3H),
2.60 (s, 3H), 4.27 (q, J = 7.2 Hz, 2H), 7.13 (s,
1H), 7.53 (d, J = 8.4 Hz, 2H), 7.74 (d, J = 8.4 Hz, 2H), 8.22 (s, 2H); 13C{1H} NMR (150
MHz, DMSO-d6): δ 14.2, 14.3, 59.6,
75.0, 102.3, 103.7, 116.4, 122.6, 130.5, 131.6, 136.8, 141.9, 142.2,
147.9, 155.9, 162.9; MS (EI): m/z (%) 400 (M+ + 2, 96.33), 399 (M+ + 1, 19.98),
398 (M+, 100). HRMS (EI): m/z calcd. for C18H15BrN4O2 (M+) 398.0373, found 398.0373.

7-Amino-6-cyano-5-(4-fluorophenyl)-2-methylpyrazolo[1,5-a]pyridine-3-carboxylic acid ethyl ester (4f)
Recrystallized from EtOH/dioxane mixture (4:1), as white
crystals, yield: 0.80 g (78%), mp 199–200 °C; IR (KBr):
ν/cm–1 3451, 3321 (NH2), 2216 (CN),
1707 (CO); 1H NMR (600 MHz, DMSO-d6): δ 1.30 (t, J = 7.2 Hz, 3H), 2.61
(s, 3H), 4.28 (q, J = 7.2 Hz, 2H), 7.14 (s, 1H),
7.36–7.39 (m, 2H), 7.63–7.65 (m, 2H), 8.20 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 14.76, 14.79, 60.1, 75.9, 102.7, 104.3, (116.04,
116.18) (d, 2JCF = 21.0 Hz),
117.0, (131.08, 131.14) (d, 3JCF = 9.0 Hz), (134.47, 134.49) (d, 4JCF = 3.0 Hz), 142.69, 142.73, 148.4, 156.4, (162.22, 163.85
ppm) (d, 1JCF = 244.5 Hz),
163.4; MS (EI): m/z (%) 339 (M+ + 1, 23.89), 338 (M+, 100). HRMS (EI): m/z calcd. for C18H15FN4O2 (M+) 338.1174, found 338.1175.

7-Amino-6-cyano-2,5-diphenylpyrazolo[1,5-a]pyridine-3-carboxylic
acid ethyl ester (4g)
Recrystallized from EtOH/DMF
mixture (3:1), as buff crystals, yield: 0.94 g (82%), mp 201–202
°C; IR (KBr): ν/cm–1 3444, 3323 (NH2), 2212 (CN), 1687 (CO); 1H NMR (600 MHz, DMSO-d6): δ 1.18 (t, J = 7.2
Hz, 3H), 4.20 (q, J = 7.2 Hz, 2H), 7.29 (s, 1H),
7.48–7.50 (m, 4H), 7.52–7.54 (m, 3H), 7.55 (d, J = 8.4 Hz, 2H), 7.80–7.82 (m, 2H), 8.29 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 14.0, 59.7, 75.8, 101.6, 104.4, 116.4, 124.2, 127.6,
128.3, 128.7, 129.1, 129.9, 131.9, 137.6, 142.9, 143.3, 148.2, 156.9,
162.4; MS (EI): m/z (%) 383 (M+ + 1, 19.98), 382 (M+, 100). HRMS (EI): m/z calcd. for C23H18N4O2 (M+) 382.1424, found 382.1424.

7-Amino-6-cyano-2-phenyl-5-p-tolylpyrazolo[1,5-a]pyridine-3-carboxylic acid ethyl ester (4h)
Recrystallized from EtOH/DMF mixture (3:1), as pale yellow
crystals, yield: 1.00 g (87%), mp 273–274 °C; IR (KBr):
ν/cm–1 3460, 3323 (NH2), 2216 (CN),
1714 (CO); 1H NMR (600 MHz, DMSO-d6): δ 1.18 (t, J = 7.2 Hz, 3H), 2.40
(s, 3H), 4.19 (q, J = 7.2 Hz, 2H), 7.27 (s, 1H),
7.36 (d, J = 7.8 Hz, 2H), 7.48–7.52 (m, 5H),
7.80–7.81 (m, 2H), 8.26 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 14.0,
20.8, 59.7, 75.8, 101.5, 104.2, 116.5, 127.6, 128.2, 129.1, 129.3,
129.9, 131.9, 134.7, 138.8, 143.0, 143.4, 148.2, 156.9, 162.4; MS
(EI): m/z (%) 397 (M+ + 1, 24.15), 3 96 (M+, 100). HRMS (EI): m/z calcd. for C24H20N4O2 (M+) 396.1581, found 396.1580.

7-Amino-6-cyano-5-(4-methoxyphenyl)-2-phenylpyrazolo[1,5-a]pyridine-3-carboxylic acid ethyl ester (4i)
Recrystallized from EtOH/DMF mixture (3:1), as yellow
crystals, yield: 1.05 g (85%), mp 260–261 °C; IR (KBr):
ν/cm–1 3438, 3321 (NH2), 2212 (CN),
1714 (CO); 1H NMR (600 MHz, DMSO-d6): δ 1.18 (t, J = 7.2 Hz, 3H), 3.84
(s, 3H), 4.19 (q, J = 7.2 Hz, 2H), 7.10 (d, J = 9.0 Hz, 2H), 7.25 (s, 1H), 7.47–7.49 (m, 3H),
7.56 (d, J = 9.0 Hz, 2H), 7.79–7.80 (m, 2H),
8.23 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 14.0, 55.3, 59.7, 75.8, 101.3, 104.0,
114.1, 116.6, 127.6, 129.1, 129.70, 129.71, 129.9, 131.9, 143.0, 143.1,
148.1, 156.9, 160.0, 162.4; MS (EI): m/z (%) 413 (M+ + 1, 27.84), 412 (M+, 100). HRMS
(EI): m/z calcd. for C24H20N4O3 (M+) 412.1530,
found 412.1529. Crystal data, moiety formula: C24H20N4O3, M = 412.44,
triclinic, a = 8.2355(3) Å, b = 10.4603(4) Å, c = 12.9164(4) Å, V = 1021.68(6) Å3, α = 105.604(2)°,
β = 90.933(2)°, γ = 106.617(2)°, space group: P1̅, Z = 2, Dcalc = 1.341 g·cm–3, no. of reflection
measured 3541, θmax = 66.56°, R1 = 0.0435 (CCDC 1916934).83

7-Amino-5-(4-chlorophenyl)-6-cyano-2-phenylpyrazolo[1,5-a]pyridine-3-carboxylic acid ethyl ester(4j)
Recrystallized from EtOH/DMF mixture (3:1), as buff crystals,
yield: 0.95 g (76%), mp 291–292 °C; IR (KBr): ν/cm–1 3435, 3307 (NH2), 2218 (CN), 1714 (CO); 1H NMR (600 MHz, DMSO-d6): δ
1.18 (t, J = 7.2 Hz, 3H), 4.21 (q, J = 7.2 Hz, 2H), 7.28 (s, 1H), 7.49–7.51 (m, 3H), 7.63–7.66
(m, 4H), 7.95 (d, J = 8.4 Hz, 2H), 8.34 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 14.0, 59.8, 75.6, 101.8, 104.4, 116.3, 127.6, 128.7,
129.2, 129.9, 130.3, 131.8, 134.0, 136.4, 142.0, 142.9, 148.2, 156.9,
162.4; MS (EI): m/z (%) 418 (M+ + 2, 30.58), 417 (M+ + 1, 22.89), 416 (M+, 100). HRMS (EI): m/z calcd. for
C23H17ClN4O2 (M+) 416.1035, found 416.1035.

7-Amino-5-(4-bromophenyl)-6-cyano-2-phenylpyrazolo[1,5-a]pyridine-3-carboxylic acid ethyl ester(4k)
Recrystallized from EtOH/DMF mixture (3:1), as buff crystals,
yield: 1.05 g (77%), mp 259–260 °C; IR (KBr): ν/cm–1 3429, 3309 (NH2), 2216 (CN), 1714 (CO); 1H NMR (600 MHz, DMSO-d6): δ
1.18 (t, J = 7.2 Hz, 3H), 4.20 (q, J = 7.2 Hz, 2H), 7.28 (s, 1H), 7.48–7.50 (m, 3H), 7.57 (d, J = 8.4 Hz, 2H), 7.76 (d, J = 8.4 Hz, 2H),
7.80–7.81 (m, 2H), 8.33 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 14.0,
59.8, 75.5, 101.8, 104.4, 116.3, 122.7, 127.6, 129.2, 129.9, 130.5,
131.7, 131.8, 136.8, 142.1, 142.9, 148.2, 156.9, 162.4; MS (EI): m/z (%) 462 (M+ + 2, 99.87),
461 (M+ + 1, 26.95), 460 (M+, 100). HRMS (EI): m/z calcd. for C23H17BrN4O2 (M+) 460.0529, found 460.0528.

7-Amino-5-(4-fluorophenyl)-6-cyano-2-phenylpyrazolo[1,5-a]pyridine-3-carboxylic acid ethyl ester(4l)
Recrystallized from EtOH/dioxane mixture (1:1), as yellow
white crystals, yield: 0.88 g (73%), mp 234–235 °C; IR
(KBr): ν/cm–1 3444, 3311 (NH2),
2222 (CN), 1714 (CO); 1H NMR (600 MHz, DMSO-d6): δ 1.19 (t, J = 7.2 Hz, 3H),
4.22 (q, J = 7.2 Hz, 2H), 7.28 (s, 1H), 7.41 (t, J = 9.0 Hz, 2H), 7.49–7.51 (m, 3H), 7.67–7.70
(m, 2H), 7.81–7.83 (m, 2H), 8.30 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ
14.0, 59.7, 75.8, 101.7, 104.4, (115.59, 115.73) (d, 2JCF = 21.0 Hz), 116.4, 127.6, 129.2, 129.9, (130.62,
130.68) (d, 3JCF = 9.0 Hz),
131.9, (133.97, 133.99) (d, 4JCF = 3.0 Hz), 142.3, 142.9, 148.1, 156.9 (161.76, 163.40 ppm) (d, 1JCF = 246 Hz), 162.4; MS (EI): m/z (%) 401 (M+ + 1, 21.89),
400 (M+, 100). HRMS (EI): m/z calcd. for C23H17FN4O2 (M+) 400.1330, found 400.1330.

7-Amino-6-cyano-2-ethyl-5-phenylpyrazolo[1,5-a]pyridine-3-carboxylic acid methyl ester (4m)
Recrystallized from EtOH as pale yellow crystals, yield:
0.85 g (89%),
mp 209–210 °C; IR (KBr): ν/cm–1 3452, 3309 (NH2), 2218 (CN), 1705 (CO); 1H
NMR (600 MHz, DMSO-d6): δ 1.29 (t, J = 7.2 Hz, 3H), 3.02 (q, J = 7.2 Hz, 2H),
3.80 (s, 3H), 7.13 (s, 1H), 7.50–7.57 (m, 5H), 8.14 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 12.9, 21.3, 51.0, 75.4, 101.2, 104.0, 116.5, 128.4,
128.6, 129.0, 137.6, 142.3, 143.2, 147.9, 161.0, 163.2; MS (EI): m/z (%) 321 (M+ + 1, 18.15),
320 (M+, 100). HRMS (EI): m/z calcd. for C18H16N4O2 (M+) 320.1268, found 320.1267.

7-Amino-6-cyano-2-ethyl-5-p-tolylpyrazolo[1,5-a]pyridine-3-carboxylic
acid methyl ester (4n)
Recrystallized from EtOH
as yellow crystals, yield: 0.90
g (91%), mp 220–221 °C; IR (KBr): ν/cm–1 3462, 3329 (NH2), 2212 (CN), 1705 (CO); 1H
NMR (600 MHz, DMSO-d6): δ 1.27 (t, J = 7.2 Hz, 3H), 2.37 (s, 3H), 3.00 (q, J = 7.2 Hz, 2H), 3.79 (s, 3H), 7.09 (s, 1H), 7.30 (d, J = 7.8 Hz, 2H), 7.42 (d, J = 7.8 Hz, 2H), 8.07 (s,
2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 12.8, 20.8, 21.3, 51.0, 75.4, 101.0, 103.8,
116.6, 128.2, 129.1, 134.7, 138.6, 142.3, 143.1, 147.9, 160.9, 163.1;
MS (EI): m/z (%) 335 (M+ + 1, 22.45), 334 (M+, 100). HRMS (EI): m/z calcd. for C19H18N4O2 (M+) 334.1424, found 334.1425.

7-Amino-6-cyano-2-ethyl-5-(4-methoxyphenyl)pyrazolo[1,5-a]pyridine-3-carboxylic acid methyl ester (4o)
Recrystallized from EtOH as yellow crystals, yield: 0.88
g (84%), mp 198–199 °C; IR (KBr): ν/cm–1 3471, 3363 (NH2), 2206 (CN), 1716 (CO); 1H
NMR (600 MHz, DMSO-d6): δ 1.28 (t, J = 7.2 Hz, 3H), 3.00 (q, J = 7.2 Hz, 2H),
3.80 (s, 3H), 3.83 (s, 3H), 7.06–7.08 (m, 3H), 7.50 (d, J = 8.4 Hz, 2H), 8.05 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 12.8,
21.3, 51.0, 55.2, 75.4, 100.9, 103.6, 114.0, 116.7, 129.7, 142.3,
142.9, 147.9, 159.9, 160.9, 163.1; MS (EI): m/z (%) 351 (M+ + 1, 18.74), 350 (M+, 100). HRMS (EI): m/z calcd. for
C19H18N4O3 (M+) 350.1373, found 350.1373.

7-Amino-5-(4-chlorophenyl)-6-cyano-2-ethylpyrazolo[1,5-a]pyridine-3-carboxylic acid methyl ester (4p)
Recrystallized from EtOH/dioxane mixture (2:1), as canary
yellow crystals, yield: 0.99 g (93%), mp 238–239 °C; IR
(KBr): ν/cm–13462, 3344 (NH2), 2212 (CN),
1714 cm–1 (CO); 1H NMR (600 MHz, DMSO-d6): δ 1.29 (t, J = 7.2
Hz, 3H), 3.01 (q, J = 7.2 Hz, 2H), 3.80 (s, 3H),
7.13 (s, 1H), 7.59 (s, 4H), 8.20 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 12.9,
21.3, 51.0, 75.2, 101.4, 104.0, 116.3, 128.6, 130.2, 133.9, 136.4,
141.9, 142.2, 147.9 161.0, 163.1; MS (EI): m/z (%) 356 (M+ + 2, 31.08), 355 (M+ + 1, 20.13), 354 (M+, 100). HRMS (EI): m/z calcd. for C18H15 ClN4O2 (M+) 354.0878, found 354.0879.

7-Amino-5-(4-bromophenyl)-6-cyano-2-ethylpyrazolo[1,5-a]pyridine-3-carboxylic acid methyl ester (4q)
Recrystallized from EtOH/dioxane mixture (2:1), as yellow
crystals, yield: 1.05 g (90%), mp 247–248 °C; IR (KBr):
ν/cm–1 3441, 3311 (NH2), 2216 (CN),
1703 (CO); 1H NMR (600 MHz, DMSO-d6): δ 1.29 (t, J = 7.2 Hz, 3H), 3.01
(q, J = 7.2 Hz, 2H), 3.81 (s, 3H), 7.12 (s, 1H),
7.51 (d, J = 8.4 Hz, 2H), 7.72 (d, J = 8.4 Hz, 2H), 8.18 (s, 2H); 13C{1H} NMR (150
MHz, DMSO-d6): δ 12.9, 21.3, 51.0,
75.1, 101.4, 103.9, 116.4, 122.6, 130.5, 131.6, 136.7, 141.9, 142.2,
147.9 161.0, 163.1; MS (EI): m/z (%) 400 (M+ + 2, 99.62), 399 (M+ + 1, 18.78),
398 (M+, 100). HRMS (EI): m/z calcd. for C18H15 BrN4O2 (M+) 398.0373, found 398.0374.

3-Acetyl-7-amino-2-methyl-5-phenylpyrazolo[1,5-a]pyridine-6-carbonitrile (4r)
Recrystallized
from EtOH/dioxane mixture (2:1), as yellow crystals, yield: 0.70 g
(81%), mp 244–245 °C; IR (KBr): ν/cm–1 3458, 3330 (NH2), 2212 (CN), 1649 cm–1 (CO); 1H NMR (600 MHz, DMSO-d6): δ 2.51 (s, 3H), 2.65 (s, 3H), 7.27 (s, 1H), 7.50–7.55
(m, 3H), 7.59–7.61 (m, 2H), 8.16 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ
15.4, 30.5, 75.7, 104.3, 112.1, 116.4, 128.4, 128.6, 129.0, 137.5,
141.9, 143.7, 147.7, 155.2, 191.7; MS (EI): m/z (%) 291 (M+ + 1, 9.18), 290 (M+,
46.05), 275 (M+-15, 100). HRMS (EI): m/z calcd. for C17H14N4O (M+) 290.1162, found 290.1162. Crystal data,
moiety formula: C17H14N4O, M = 290.32 monoclinic, a = 4.3144(6) Å, b = 10.7340(12) Å, c = 31.118(5) Å, V = 1441.0(3) Å3, α = γ = 90°,
β = 90.599(6)°, space group: P21/n (#14), Z = 4, Dcalc = 1.338 g·cm–3, no. of reflection
measured 3034, 2θmax = 50.10°, R1 = 0.0783 (ref CCDC 1940357).83

3-Acetyl-7-amino-2-methyl-5-p-tolylpyrazolo[1,5-a]pyridine-6-carbonitrile
(4s)
Recrystallized
from EtOH/dioxane mixture (2:1), as yellow crystals, yield: 0.75 g
(83%), mp above 300 °C; IR (KBr): ν/cm–1 3464, 3330 (NH2), 2216 (CN), 1651 (CO); 1H
NMR (600 MHz, DMSO-d6): δ 2.39 (s,
3H), 2.52 (s, 3H), 2.66 (s, 3H), 7.27 (s, 1H), 7.33 (d, J = 7.8 Hz, 2H), 7.50 (d, J = 7.8 Hz, 2H), 8.15 (s,
2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 15.4, 20.8, 30.5, 75.7, 104.1, 112.0, 116.5,
128.3, 129.2, 134.7, 138.7, 142.0, 143.8, 147.7, 155.2, 191.7; MS
(EI): m/z (%) 305 (M+ + 1, 12.36), 304 (M+, 52.12), 289 (M+-15,
100). HRMS (EI): m/z calcd. for
C18H16N4O (M+) 304.1319,
found 304.1319.

3-Acetyl-7-amino-5-(4-chlorophenyl)-2-methylpyrazolo[1,5-a]pyridine-6-carbonitrile (4t)
Recrystallized
from EtOH/dioxane mixture (2:1), as yellow crystals, yield: 0.86 g
(89%), mp 272–273 °C; IR (KBr): ν/cm–1 3438, 3309 (NH2), 2220 (CN), 1653 (CO); 1H
NMR (600 MHz, DMSO-d6): δ 2.52 (s,
3H), 2.66 (s, 3H), 7.27 (s, 1H), 7.59–7.64 (m, 4H), 8.22 (s,
2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 15.4, 30.5, 75.4, 104.3, 112.2, 116.3, 128.6,
130.3, 134.0, 136.3, 141.9, 142.4, 147.7, 155.2, 191.8; MS (EI): m/z (%) 326 (M+ + 2, 15.12),
325 (M+ + 1, 9.13), 324 (M+, 46.78), 309 (M+ – 15, 100). HRMS (EI): m/z calcd. for C17H13ClN4O (M+) 324.0772, found 324.0772.

3-Acetyl-7-amino-5-(4-bromophenyl)-2-methylpyrazolo[1,5-a]pyridine-6-carbonitrile (4u)
Recrystallized
from EtOH/dioxane mixture (2:1), as yellow white crystals, yield:
0.95 g (87%), mp 284–285 °C; IR (KBr): ν/cm–1 3433, 3311 (NH2), 2218 (CN), 1653 (CO); 1H NMR (600 MHz, DMSO-d6): δ
2.52 (s, 3H), 2.66 (s, 3H), 7.27 (s, 1H), 7.56 (d, J = 8.4 Hz, 2H), 7.74 (d, J = 7.8 Hz, 2H), 8.22 (s,
2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 15.4, 30.6, 75.6, 104.2, 112.2, 116.3, 122.6,
130.6, 131.6, 136.7, 141.9, 142.4, 147.7, 155.2, 191.8; MS (EI): m/z (%) 370 (M+ + 2, 57.12),
369 (M+ + 1, 11.13), 368 (M+, 57.33), 353 (M+ – 15, 100). HRMS (EI): m/z calcd. for C17H13BrN4O (M+) 368.0267, found 368.0267.

3-Acetyl-7-amino-5-(4-flurophenyl)-2-methylpyrazolo[1,5-a]pyridine-6-carbonitrile (4v)
Recrystallized
from EtOH/dioxane mixture (2:1), as yellow white crystals, yield:
0.74 g (80%), mp 223–224 °C; IR (KBr): ν/cm–1 3444, 3323 (NH2), 2218 (CN), 1651 cm–1 (CO); 1H NMR (600 MHz, DMSO-d6): δ 2.51 (s, 3H), 2.64 (s, 3H), 7.24 (s, 1H),
7.35–7.38 (m, 2H), 7.64–7.66 (m, 2H), 8.17 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 15.4, 30.5, 75.7, 104.3, 112.1, (115.46, 115.60)
(d, 2JCF = 21.0 Hz), 116.4,
(130.66, 130.71) (d, 3JCF =
7.5 Hz), (133.89, 133.91) (d, 4JCF = 3.0 Hz), 141.9, 142.6, 147.6, 155.2, (161.74, 163.37 ppm) (d, 1JCF = 244.5 Hz) and 191.7 ppm
(CN, Ar–C and CO); MS (EI): m/z (%) 309 (M+ + 1, 8.24), 308 (M+, 43.89), 293
(M+ – 15, 100). HRMS (EI): m/z calcd. for C17H13FN4O
(M+) 308.1068, found 308.1068.

7-Amino-3,3-dimethyl-1-oxo-9-phenyl-1,2,3,4-tetrahydropyrido[1,2-b]indazole-8-carbonitrile (6a)
Recrystallized
from EtOH/dioxane mixture (3:1), as yellow crystals, yield: 0.82 g
(83%), mp 272–273 °C; IR (KBr): ν/cm–1 3435, 3291 (NH2), 2212 (CN), 1660 (CO); 1H
NMR (600 MHz, DMSO-d6): δ 1.08 (s,
6H), 2.40 (s, 2H), 2.88 (s, 2H), 7.14 (s, 1H), 7.52–7.56 (m,
3H), 7.60–7.61 (m, 2H), 8.25 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 28.0,
34.9, 36.3, 51.9, 76.6, 103.3, 108.2, 116.3, 128.3, 128.6, 129.2,
137.2, 139.1, 144.8, 148.1, 160.7, 191.9; MS (EI): m/z (%) 331 (M+ + 1, 19.04), 330 (M+, 100). HRMS (EI): m/z calcd.
for C20H18N4O (M+) 330.1475,
found 330.1476. Crystal data, moiety formula: C20H18N4O, M = 330.39, monoclinic, a = 5.9727(5) Å, b = 25.0246(18) Å, c = 11.9182(9) Å, V = 1727.8(2) Å3, α = γ = 90°, β = 104.090(7)°,
space group: P21/c, Z = 4, Dcalc = 1.270 g·cm–3, no. of reflections measured 3034, 2θmax = 50.10°, R1 = 0.0441 (CCDC 1916935).83

7-Amino-3,3-dimethyl-1-oxo-9-p-tolyl-1,2,3,4-tetrahydropyrido[1,2-b]indazole-8-carbonitrile
(6b)
Recrystallized
from EtOH/dioxane mixture (3:1), as yellow white crystals, yield:
0.82 g (79%), mp 261–262 °C; IR (KBr): ν/cm–1 3444, 3292 (NH2), 2214 (CN), 1658 (CO); 1H NMR (600 MHz, DMSO-d6): δ
1.07 (s, 6H), 2.38 (s, 2H), 2.39 (s, 3H), 2.86 (s, 2H), 7.11 (s, 1H),
7.33 (d, J = 8.4 Hz, 2H), 7.49 (d, J = 8.4 Hz, 2H), 8.25 (s, 2H); 13C{1H} NMR (150
MHz, DMSO-d6): δ 20.8, 28.0, 34.9,
36.3, 51.9, 76.6, 103.1, 108.1, 116.4, 128.2, 129.2, 134.3, 138.8,
139.7, 144.9, 148.1, 160.7, 191.8; MS (EI): m/z (%) 345 (M+ + 1, 23.87), 344 (M+, 100). HRMS (EI): m/z calcd. for
C21H20N4O (M+) 344.1632,
found 344.1632.

7-Amino-9-(4-chlorophenyl)-3,3-dimethyl-1-oxo-1,2,3,4-tetrahydropyrido[1,2-b]indazole-8-carbonitrile (6c)
Recrystallized
from EtOH/dioxane mixture (3:1), as yellow crystals, yield: 0.93 g
(85%), mp 223–224 °C; IR (KBr): ν/cm–1 3346, 3290 (NH2), 2214 (CN), 1655 (CO); 1H
NMR (600 MHz, DMSO-d6): δ 1.07 (s,
6H), 2.39 (s, 2H), 2.87 (s, 2H), 7.12 (s, 1H), 7.59–7.63 (m,
4H), 8.32 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 27.8, 34.6, 36.3, 51.9, 76.4, 103.4,
108.3, 115.9, 128.5, 130.0, 133.9, 135.9, 139.0, 143.3, 147.9, 160.6,
191.6; MS (EI): m/z (%) 366 (M+ + 2, 33.16), 365 (M+ + 1, 23.09), 364 (M+, 100). HRMS (EI): m/z calcd. for
C20H17ClN4O (M+) 364.1085,
found 364.1085. Crystal data, sum formula: C22H23ClN4O2S, moiety formula: C24H22N6O, M = 364.84, monoclinic, a = 5.8529(2) Å, b = 19.0224(6) Å, c = 20.2441(6) Å, V = 2251.86(12)
Å3, α = γ = 90°, β = 92.438(2)°,
space group P121/c1, Z = 4, Dcalc = 1.307 g·cm–3, no. of reflections measured: 3821, θmax = 66.54°, R1 = 0.0804 (CCDC 1916936).83

7-Amino-9-(4-bromophenyl)-3,3-dimethyl-1-oxo-1,2,3,4-tetrahydropyrido[1,2-b]indazole-8-carbonitrile (6d)
Recrystallized
from EtOH/dioxane mixture (2:1), as yellow crystals, yield: 1.06 g
(87%), mp 274–275 °C; IR (KBr): ν/cm–1 3444, 3288 (NH2), 2214 (CN), 1655 (CO); 1H
NMR (600 MHz, DMSO-d6): δ 1.11 (s,
6H), 2.41 (s, 2H), 2.90 (s, 2H), 7.21 (s, 1H), 7.56 (d, J = 8.4 Hz, 2H), 7.72 (d, J = 8.4 Hz, 2H), 7.90 (s,
2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 27.5, 34.3, 36.2, 51.8, 76.4, 103.4, 108.1,
115.4, 122.2, 129.9, 131.1, 136.1, 138.7, 142.9, 147.6, 160.3, 191.1;
MS (EI): m/z (%) 410 (M+ + 2, 99.97), 409 (M+ + 1, 21.73), 408 (M+,
100). HRMS (EI): m/z calcd. for
C20H17BrN4O (M+) 408.0580,
found 408.0581. Crystal data, moiety formula: C20H17BrN4O, M = 409.29, monoclinic, a = 6.7934(7) Å, b = 29.438(3) Å, c = 9.5955(9) Å, V = 1880.3(3) Å3, α = γ = 90°, β = 101.519(7)°,
space group P21/c, Z = 4, Dcalc = 1.446 g·cm–3, no. of reflections measured: 3294, θmax = 25.007°, R1 = 0.0701 (CCDC 1916937).83

7-Amino-9-(4-fluorophenyl)-3,3-dimethyl-1-oxo-1,2,3,4-tetrahydropyrido[1,2-b]indazole-8-carbonitrile (6e)
Recrystallized
from EtOH as yellow crystals, yield: 0.88 g (84%), mp 224–225
°C; IR (KBr): ν/cm–1 3480, 3324 (NH2), 2216 (CN), 1653 (CO); 1H NMR (600 MHz, DMSO-d6): δ 1.09 (s, 6H), 2.40 (s, 2H), 2.88
(s, 2H), 7.13 (s, 1H), 7.36–7.39 (m, 2H), 7.65–7.68
(m, 2H), 8.26 (s, 2H); 13C{1H} NMR (150 MHz,
DMSO-d6): δ 28.0, 34.9, 36.3, 51.9,
76.6, 103.4, 108.6, (115.56, 115.70) (d, 2JCF = 21.0 Hz), 116.3, (130.65, 130.71) (d, 3JCF = 9.0 Hz), (133.63, 133.65) (d, 4JCF = 3.0 Hz), 139.2, 143.8, 148.0,
160.7, (161.80, 163.43 ppm) (d, 1JCF = 244.5 Hz), 191.9; MS (EI): m/z (%) 349 (M+ + 1, 38.95), 348 (M+, 100). HRMS (EI): m/z calcd. for
C20H17FN4O (M+) 348.1381,
found 348.1381.

7-Amino-1-oxo-9-phenyl-1,2,3,4-tetrahydropyrido[1,2-b]indazole-8-carbonitrile (6f)
Recrystallized
from EtOH/dioxane mixture (3:1), as yellow crystals, yield: 0.78 g
(86%), mp 261–262 °C; IR (KBr): ν/cm–1 3429, 3298 (NH2), 2213 (CN), 1654 (CO); 1H
NMR (600 MHz, DMSO-d6): δ 2.14 (pentet, J = 6.0 Hz, 2H), 2.50 (t, J = 6.0 Hz, 2H),
2.99 (t, J = 6.0 Hz, 2H), 7.16 (s, 1H), 7.53–7.57
(m, 3H), 7.60–7.62 (m, 2H), 8.29 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ
22.8, 23.1, 38.1, 76.7, 103.4, 109.4, 116.3, 128.4, 128.7, 129.2,
137.2, 139.4, 144.8, 148.0, 161.6, 192.6; MS (EI): m/z (%) 303 (M+ + 1, 21.72), 302 (M+, 100). HRMS (EI): m/z calcd.
for C18H14N4O (M+) 302.1162,
found 302.1162.

7-Amino-9-(4-chlorophenyl)-1-oxo-1,2,3,4-tetrahydropyrido[1,2-b]indazole-8-carbonitrile (6g)
Recrystallized
from EtOH/dioxane mixture (3:1), as yellow crystals, yield: 0.91 g
(90%), mp 299–300 °C; IR (KBr): ν/cm–1 3435, 3319 (NH2), 2214 (CN), 1655 (CO); 1H
NMR (600 MHz, DMSO-d6): δ 2.11 (pentet, J = 6.0 Hz, 2H), 2.48 (t, J = 6.0 Hz, 2H),
2.97 (t, J = 6.0 Hz, 2H), 7.11 (s, 1H), 7.58–7.62
(m, 4H), 8.31 (s, 2H); 13C{1H} NMR (150 MHz,
DMSO-d6): δ 22.8, 23.1, 38.1, 76.5,
103.4, 109.5, 116.2, 128.7, 130.3, 134.1, 136.0, 139.2, 143.4, 148.0,
161.6, 192.6; MS (EI): m/z (%) 338
(M+ + 2, 32.78), 337 (M+ + 1, 21.27), 336 (M+, 100). HRMS (EI): m/z calcd.
for C18H13ClN4O (M+) 336.0772,
found 336.0772.

7-Amino-9-(4-bromophenyl)-1-oxo-1,2,3,4-tetrahydropyrido[1,2-b]indazole-8-carbonitrile (6h)
Recrystallized
from EtOH/dioxane mixture (2:1), as canary yellow crystals, yield:
1.00 g (88%), mp 295–296 °C; IR (KBr): ν/cm–1 3429, 3328 (NH2), 2212 (CN), 1655 (CO); 1H NMR (600 MHz, DMSO-d6): δ
2.12 (pentet, J = 6.0 Hz, 2H), 2.48 (t, J = 6.0 Hz, 2H), 2.98 (t, J = 6.0 Hz, 2H), 7.12 (s,
1H), 7.55 (d, J = 8.4 Hz, 2H), 7.74 (d, J = 8.4 Hz, 2H), 8.32 (s, 2H); 13C{1H} NMR (150
MHz, DMSO-d6): δ 22.8, 23.1, 38.1,
76.4, 103.3, 109.5, 116.2, 122.8, 130.5, 131.6, 136.4, 139.3, 143.5,
148.0, 161.6, 192.6; MS (EI): m/z (%) 382 (M+ + 2, 99.65), 381 (M+ + 1, 20.08),
380 (M+, 100). HRMS (EI): m/z calcd. for C18H13BrN4O (M+) 380.0267, found 380.0269.

7-Amino-9-(4-fluorophenyl)-1-oxo-1,2,3,4-tetrahydropyrido[1,2-b]indazole-8-carbonitrile (6i)
Recrystallized
from EtOH/dioxane mixture (2:1), as yellow crystals, yield: 0.77 g
(80%), mp 275–276 °C; IR (KBr): ν/cm–1 3436, 3294 (NH2), 2214 (CN), 1656 (CO); 1H
NMR (600 MHz, DMSO-d6): δ 2.13 (pentet, J = 6.0 Hz, 2H), 2.50 (t, J = 6.0 Hz, 2H),
2.99 (t, J = 6.0 Hz, 2H), 7.14 (s, 1H), 7.37–7.41
(m, 2H), 7.65–7.68 (m, 2H), 8.31 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ
22.8, 23.1, 38.1, 76.7, 103.4, 109.4, (115.56, 115.71) (d, 2JCF = 22.5 Hz), 116.3, (130.66, 130.71)
(d, 3JCF = 7.5 Hz), (133.60,
133.62) (d, 4JCF = 3.0 Hz),
139.3, 143.8, 148.0, 161.6, (161.80, 163.43) (d, 1JCF = 244.5 Hz), 192.6; MS (EI): 321 (M+ + 1, 21.02), 320 (M+, 100). HRMS (EI): m/z calcd. for C18H13FN4O (M+) 320.1068, found 320.1067.

6-Amino-1-oxo-8-phenyl-2,3-dihydro-1H-cyclopenta[3,4]pyrazolo[1,5-a]pyridine-7-carbonitrile
(8a)
Recrystallized
from EtOH/dioxane mixture (1:1), as pale yellow crystals, yield: 0.62
g (72%), mp 231–232 °C; IR (KBr): ν/cm–1 3413, 3288 (NH2), 2215 (CN), 1652 (CO); 1H
NMR (600 MHz, DMSO-d6): δ 2.62 (t, J = 6.0 Hz, 2H), 2.89 (t, J = 6.0 Hz, 2H),
7.13 (s, 1H), 7.55–7.59 (m, 3H), 7.69–7.72 (m, 2H),
8.33 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 24.9, 33.5, 76.3, 103.7, 109.5,
116.4, 128.5, 129.0, 129.4, 136.9, 139.1, 144.5, 147.9, 161.5, 192.1;
MS (EI): m/z (%) 289 (M+ + 1, 26.01), 288 (M+, 100). HRMS (EI): m/z calcd. for C17H12N4O (M+) 288.1006, found 288.1005.

6-Amino-8-(4-chlorophenyl)-1-oxo-2,3-dihydro-1H-cyclopenta[3,4]pyrazolo[1,5-a]pyridine-7-carbonitrile (8b)
Recrystallized
from EtOH/dioxane mixture (2:1), as yellow crystals, yield: 0.71 g
(74%), mp 253–254 °C; IR (KBr): ν/cm–1 3422, 3314 (NH2), 2216 (CN), 1656 (CO); 1H
NMR (600 MHz, DMSO-d6): δ 2.59 (t, J = 6.0 Hz, 2H), 2.83 (t, J = 6.0 Hz, 2H),
7.14 (s, 1H), 7.61–7.63 (m, 4H), 8.36 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 24.7, 33.3, 76.7, 103.5, 109.8, 115.9, 129.0, 129.9, 134.2,
135.9, 139.5, 143.1, 147.8, 161.5, 192.2; MS (EI): m/z (%) 324 (M+ + 2, 36.02), 323 (M+ + 1, 24.15), 322 (M+, 100). HRMS (EI): m/z calcd. for C17H11ClN4O (M+) 322.0616, found 322.0617

7-Amino-5-(4-chlorophenyl)-2-phenylH-pyrazolo[1,5-a]pyridine-3,6-dicarbonitrile
(10)
Recrystallized from dioxane, as beige crystals,
yield: 0.76 g (69%),
mp 270–271 °C; IR (KBr): ν/cm–1 3415, 3298 (NH2), 2214, 2219 (2CN); 1H NMR
(600 MHz, DMSO-d6): δ 7.35 (s, 1H),
7.44–7.47 (m, 3H), 7.65–7.67 (m, 4H), 7.91 (d, J = 8.4 Hz, 2H), 8.36 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 76.1,
102.0, 113.6, 116.2, 127.8, 128.5, 129.6, 129.8, 130.8, 132.0, 133.8,
136.6, 141.9, 143.0, 148.5, 156.8, 162.8; MS (EI): m/z (%) 371 (M+ + 2, 33.26), 370 (M+ + 1, 23.12), 369 (M+, 100). HRMS (EI): m/z calcd. for C21H12ClN5 (M+) 369.0776, found 369.0776.

Supporting Information Available
The
Supporting Information
is available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.9b02430.1H
NMR, 13C NMR, MS, HRMS, and
IR spectra for the reported compounds (PDF)

Crystal data for 4i (CIF)

Crystal data
for 4r (CIF)

Crystal data for 6a (CIF)

Crystal data for 6c (CIF)

Crystal
data for 6d (CIF)



Supplementary Material
ao9b02430_si_001.pdf

 ao9b02430_si_002.cif

 ao9b02430_si_003.cif

 ao9b02430_si_004.cif

 ao9b02430_si_005.cif

 ao9b02430_si_006.cif

 The authors declare no
competing financial interest.

Acknowledgments
Financial support for this
study was provided by the University
of Kuwait through a research grant (SC06/18). The facilities of Analab/SAF
supported by research grants GS01/01, GS01/05, GS01/03, and GS03/08
are gratefully acknowledged.
==== Refs
References
Eicher T. ; Hauptmann S.  The Chemistry
of Heterocycles: Structures, Reactions . Synthesis,
and Applications , 2 nd ed.; Wiley-VCH : Weinheim , 2003 .
Pozharskii A. F. ; Soldatenkov A. T. ; Katritzky A. R.  Heterocycles
in Life and Society ; John Wiley & Sons,
Ltd : West Sussex , 1997 .
a Dugger R. W. ; Ragan J. A. ; Ripin D. H. B. 
Survey of GMP
Bulk Reactions Run in a Research Facility between 1985 and 2002 . Org. Process Res. Dev. 
2005 , 9 , 253 –258 . 10.1021/op050021j . b Taylor A. P. ; Robinson R. P. ; Fobian Y. M. ; Blakemore D. C. ; Jones L. H. ; Fadeyi O. 
Modern advances in heterocyclic chemistry
in drug discovery . Org. Biomol. Chem. 
2016 , 14 , 6611 –6637 . 10.1039/C6OB00936K .27282396  c Kumar D. ; Jain S. K. 
A Comprehensive Review of N-Heterocycles as Cytotoxic
Agents . Curr. Med. Chem. 
2016 , 23 , 4338 –4394 . 10.2174/0929867323666160809093930 .27516198 
Rashad A. E. ; Hegab M. I. ; Abdel-Megeid R. E. ; Micky J. A. ; Abdel-Megeid F. M. 
Synthesis
and antiviral evaluation of some new pyrazole and fused pyrazolopyrimidine
derivatives . Bioorg. Med. Chem. 
2008 , 16 , 7102 –7106 . 10.1016/j.bmc.2008.06.054 .18635363 
a Burja B. ; Čimbora-Zovko T. ; Tomic S. ; Jelušić T. ; Kočevar M. ; Polanc S. ; Osmak M. 
Pyrazolone-fused combretastatins
and their precursors: synthesis, cytotoxicity, antitubulin activity
and molecular modeling studies . Bio. Med. Chem. 
2010 , 18 , 2375 –2387 . 10.1016/j.bmc.2010.03.006 . b Ravi C. ; Qayum A. ; Mohan D. C. ; Singh S. K. ; Adimurthy S. 
Design, synthesis and cytotoxicity studies of novel
pyrazolo[1,5-a]pyridine derivatives . Eur. J.
Med. Chem. 
2017 , 126 , 277 –285 . 10.1016/j.ejmech.2016.11.037 .27889631  c Timári G. ; Soos T. ; Hajos G. ; Messmer A. ; Nacsa J. ; Molnar J. 
Synthesis of novel
ellipticine analogues and their inhibition of Moloney leukaemia reverse
transcriptase . Bioorg. Med. Chem. Lett. 
1996 , 6 , 2831 –2836 . 10.1016/S0960-894X(96)00521-5 .
Kojima A. ; Takita S. ; Sumiya T. ; Ochiai K. ; Iwase K. ; Kishi T. ; Ohinata A. ; Yageta Y. ; Yasue T. ; Kohno Y. 
Phosphodiesterase inhibitors.
Part 6: Design, synthesis, and structure–activity
relationships of PDE4-inhibitory pyrazolo[1,5-a]pyridines
with anti-inflammatory activity . Bioorg Med.
Chem. Lett. 
2013 , 23 , 5311 –5316 . 10.1016/j.bmcl.2013.07.069 .23988356 
Mamolo M. G. ; Zampieri D. ; Falagiani V. ; Vio L. ; Fermeglia M. ; Ferrone M. ; Pricl S. ; Banfi E. ; Scialino G. 
Antifungal
and antimycobacterial activity of new N1-[1-aryl-2-(1H-Imidazol-1-yl and 1H-1,2,4-triazol-1-yl)ethylidene]pyridine-2-carboxamidrazone
derivatives: A combined experimental and computational approach . ARKIVOC 
2003 , 2004 , 231 –250 . 10.3998/ark.5550190.0005.521 .
Tang J. ; Wang B. ; Wu T. ; Wan J. ; Tu Z. ; Njire M. ; Wan B. ; Franzblauc S. G. ; Zhang T. ; Lu X. ; Ding K. 
Design, synthesis,
and biological evaluation of pyrazolo[1,5-a]pyridine-3-carboxamides
as novel antitubercular agents . ACS Med. Chem.
Lett. 
2015 , 6 , 814 –818 . 10.1021/acsmedchemlett.5b00176 .26191372 
a Lu X. Y. ; Tang J. ; Cui S. Y. ; Wan B. J. ; Franzblauc S. G. ; Zhang T. Y. ; Zhang X. T. ; Ding K. 
Pyrazolo[1,5-a]pyridine-3-carboxamide
hybrids: Design, synthesis and evaluation of antitubercular activity . Eur. J. Med. Chem. 
2017 , 125 , 41 –48 . 10.1016/j.ejmech.2016.09.030 .27654393  b Hu X. ; Wan B. ; Liu Y. ; Shen J. ; Franzblau S. G. ; Zhang T. ; Ding K. ; Lu X. 
Identification
of Pyrazolo[1,5-a]pyridine-3-carboxamide Diaryl Derivatives
as Drug Resistant Antituberculosis Agents . ACS
Med. Chem. Lett. 
2019 , 10 , 295 –299 . 10.1021/acsmedchemlett.8b00410 .30891129 
a Löber S. ; Hubner H. ; Gmeiner P. 
Fused azaindole
derivatives: molecular design, synthesis and In vitro pharmacology
leading to the preferential dopamine D3 receptor agonist FAUC 725 . Bioorg. Med. Chem. Lett. 
2002 , 12 , 2377 –2380 . 10.1016/S0960-894X(02)00390-6 .12161137  b Elsner J. ; Boeckler F. ; Heinemann F. W. ; Hübner H. ; Gmeiner P. 
Pharmacophore-guided drug discovery
investigations leading to bioactive 5-aminotetrahydropyrazolopyridines.
Implications for the binding mode of heterocyclic dopamine D3 receptor
agonists . J. Med. Chem. 
2005 , 48 , 5771 –5779 . 10.1021/jm0503805 .16134944 
a Prante O. ; Tietze R. ; Hocke C. ; Löber S. ; Hübner H. ; Kuwert T. ; Gmeiner P. 
Synthesis,
Radiofluorination, and In Vitro Evaluation of Pyrazolo[1,5-a]pyridine-Based Dopamine D4 Receptor Ligands: Discovery
of an Inverse Agonist Radioligand for PET . J.
Med. Chem. 
2008 , 51 , 1800 –1810 . 10.1021/jm701375u .18307287  b Bettinetti L. ; Schlotter K. ; Hubner H. ; Gmeiner P. 
Interactive
SAR studies: rational discovery of super-potent and highly selective
dopamine D3 receptor antagonists and partial agonists . J. Med. Chem. 
2002 , 45 , 4594 –4597 . 10.1021/jm025558r .12361386 
Umei K. ; Nishigaya Y. ; Kondo A. ; Tatani K. ; Tanaka N. ; Kohno Y. ; Seto S. 
Novel pyrazolo[1,5-a]pyridines as orally active
EP1 receptor antagonists: Synthesis,
structure-activity relationship studies, and biological evaluation . Bioorg. Med. Chem. 
2017 , 25 , 2635 –2642 . 10.1016/j.bmc.2017.03.003 .28342692 
Johns B. A. ; Gudmundsson K. S. ; Turner E. M. ; Allen S. H. ; Samano V. A. ; Ray J. A. ; Freeman G. A. ; Boyd F. L. Jr.; Sexton C. J. ; Selleseth D. W. ; Creech K. L. ; Moniri K. R. 
Pyrazolopyridine
antiherpetics: SAR of C2′ and C7 amine substituents . Bioorg. Med. Chem. 
2005 , 13 , 2397 10.1016/j.bmc.2005.01.044 .15755642 
a Kuroda S. ; Akahane A. ; Itani H. ; Nishimura S. ; Durkin K. ; Kinoshita T. ; Tenda Y. ; Sakane K. 
Discovery of FR166124, a novel water-soluble
pyrazolo[1,5-a]pyridine adenosine A1 receptor antagonist . Bioorg. Med. Chem. Lett. 
1999 , 9 , 1979 –1984 . 10.1016/S0960-894X(99)00304-2 .10450966  b Akahane A. ; Katayama H. ; Mitsunaga T. ; Kato T. ; Kinoshita T. ; Kita Y. ; Kusunoki T. ; Terai T. ; Yoshida K. ; Shiokawa Y. 
Discovery of 6-Oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)-pyridazinebutanoic acid (FK 838):
A novel non-xanthine adenosine A1 receptor antagonist with potent
diuretic activity . J. Med. Chem. 
1999 , 42 , 779 –883 . 10.1021/jm980671w .10072675 
a Cheung M. ; Harris P. A. ; Badiang J. G. ; Peckham G. E. ; Chamberlain S. D. ; Alberti M. J. ; Jung D. K. ; Harris S. S. ; Bramson N. H. ; Epperly A. H. ; Stimpson S. A. ; Peel M. R. 
The identification
of pyrazolo[1,5-a]pyridines as potent p38 kinase
inhibitors . Bioorg. Med. Chem. Lett. 
2008 , 18 , 5428 –5430 . 10.1016/j.bmcl.2008.09.040 .18818075  b Stevens K. L. ; Jung D. K. ; Alberti M. J. ; Badiang J. G. ; Peckham G. E. ; Veal J. M. ; Cheung M. P. ; Harris A. S. ; Chamberlain D. ; Peel M. R. 
Pyrazolo[1,5-a]pyridines
as p38 Kinase
Inhibitors . Org. Lett. 
2005 , 7 , 4753 –4756 . 10.1021/ol0519745 .16209527 
Kumar R. ; Kumar R. ; Chandra D. ; Sharma U. 
Cp*CoIII–catalyzed
alkylation of primary and secondary C(sp3)-H bonds of 8-alkylquinolines
with maleimides . J. Org. Chem. 
2019 , 84 , 1542 –1552 . 10.1021/acs.joc.8b02974 .30620183 
Akulov A. A. ; Varaksin M. V. ; Charushin V. N. ; Chupakhin O. N. 
Direct
functionalization of C(sp2)-H bond in nonaromatic azaheterocycles:
palladium-catalyzed cross-Dehydrogenative coupling (CDC) of 2H-imidazole
1-oxides with pyrroles and thiophenes . ACS Omega 
2019 , 4 , 825 –834 . 10.1021/acsomega.8b02916 .31459361 
Mane K. D. ; Mukherjee A. ; Vanka K. ; Suryavanshi G. 
Metal-free
regioselective cross dehydrogenative coupling of cyclic ethers and
aryl carbonyls . J. Org. Chem. 
2019 , 84 , 2039 –2047 . 10.1021/acs.joc.8b03048 .30645114 
Ren L. ; Nan G. ; Wang Y. ; Xiao Z. 
Carboxylic acid-promoted
single-step
indole construction from simple anilines and ketones via aerobic cross-dehydrogenative
coupling . J. Org. Chem. 
2018 , 83 , 14472 –14488 . 10.1021/acs.joc.8b02180 .30378428 
Shaikh M. M. ; Patel A. P. ; Chikhalia K. H. 
Copper catalyzed cross-dehydrogenative
coupling (CDC) reaction of 4-thiazolidinone with terminal alkyne . Tetrahedron 
2019 , 75 , 475 –485 . 10.1016/j.tet.2018.10.068 .
Shakoor S. M. A. ; Agarwal D. S. ; Kumar A. ; Sakhuja R. 
Copper catalyzed direct
aerobic double-oxidative crossdehydrogenative coupling of imidazoheterocycles
with aryl acetaldehydes: an articulate approach for icarbonylation
at C-3 position . Tetrahedron 
2016 , 72 , 645 –652 . 10.1016/j.tet.2015.12.012 .
Liu X. ; Zhang J. ; Ma S. ; Ma Y. ; Wang R. 
Oxidative
cross-dehydrogenative coupling between N-aryl tetrahydroisoquinolins
and 5H-oxazol-4-ones through two methodologies: copper catalysis or
a metal-free strategy . Chem. Commun. 
2014 , 50 , 15714 –15717 . 10.1039/C4CC04508D .
Dana S. ; Chowdhury D. ; Mandal A. ; Chipem F. A. S. ; Baidya M. 
Ruthenium(II)
catalysis/noncovalent interaction synergy for cross-dehydrogenative
coupling of arene carboxylic acids . ACS Catal. 
2018 , 8 , 10173 –10179 . 10.1021/acscatal.8b03392 .
Zhang R. ; Jin S. ; Liu Q. ; Lin S. ; Yan Z. 
Transition metal-free
cross-dehydrogenative coupling reaction of coumarins with acetonitrile
or acetone . J. Org. Chem. 
2018 , 83 , 13030 –13035 . 10.1021/acs.joc.8b01508 .30295495 
Wei W. ; Wang L. ; Yue H. ; Bao P. ; Liu W. ; Hu C. ; Yang D. ; Wang H. 
Metal-free visible-light-induced
C-H/C-H cross-dehydrogenative-coupling of quinoxalin-2(H)-ones with simple ethers . ACS Sustainable
Chem. Eng. 
2018 , 6 , 17252 –17257 . 10.1021/acssuschemeng.8b04652 .
Ghosh A. ; Patra A. ; Mukherjee S. ; Biju A. T. 
Synthesis of 2-aryl
naphthoquinones by the cross-dehydrogenative coupling involving an
NHC-catalyzed endo-stetter reaction . J. Org.
Chem. 
2019 , 84 , 1103 –1110 . 10.1021/acs.joc.8b02931 .30585493 
Nandwana N. K. ; Singh R. P. ; Patel O. P. S. ; Dhiman S. ; Saini H. K. ; Jha P. N. ; Kumar A. 
Design and
synthesis of imidazo/benzimidazo[1,2-c]quinazoline
derivatives and evaluation of their antimicrobial
activity . ACS Omega 
2018 , 3 , 16338 –16346 . 10.1021/acsomega.8b01592 .31458269 
Jiang Y.-T. ; Yu Z.-Z. ; Zhang Y.-K. ; Wang B. 
N-Bromosuccinimide-induced
C-H bond functionalization: An intramolecular cycloaromatization of
electron withdrawing group substituted 1-biphenyl-2-ylethanone for
the synthesis of 10-phenanthrenol . Org. Lett. 
2018 , 20 , 3728 –3731 . 10.1021/acs.orglett.8b01160 .29923730 
Lee A. ; Betori R. C. ; Crane E. A. ; Scheidt K. A. 
An enantioselective
cross-dehydrogenative coupling catalysis approach to substituted tetrahydropyrans . J. Am. Chem. Soc. 
2018 , 140 , 6212 –6216 . 10.1021/jacs.8b03063 .29714480 
Parvatkar P. T. ; Manetsch R. ; Banik B. K. 
Metal-free cross-dehydrogenative
coupling (CDC): molecular iodine as a versatile catalyst/reagent for
CDC reactions . Chem. Asian J. 
2019 , 14 , 6 –30 . 10.1002/asia.201801237 .30259704 
Dong J. ; Xia Q. ; Lv X. ; Yan C. ; Song H. ; Liu Y. ; Wang Q. 
Photoredox-mediated direct cross-dehydrogenative coupling of heteroarenes
and amines . Org. Lett. 
2018 , 20 , 5661 –5665 . 10.1021/acs.orglett.8b02389 .30179017 
Kibriya G. ; Bagdi A. K. ; Hajra A. 
Visible-light-promoted
C(sp3)-C(sp2) cross-dehydrogenative coupling
of tertiary amine
with imidazopyridine . J. Org. Chem. 
2018 , 83 , 10619 –10626 . 10.1021/acs.joc.8b01433 .30132331 
Yang K. ; Bao X. ; Yao Y. ; Qu J. ; Wang B. 
Iodine-mediated cross-dehydrogenative
coupling of pyrazolones and alkenes . Org. Biomol.
Chem. 
2018 , 16 , 6275 –6283 . 10.1039/C8OB01645C .30116825 
Yang F. ; Li Y. ; Floreancig P. E. ; Li X. ; Liu L. 
Copper-catalyzed
oxidative cross-dehydrogenative coupling of 2H-chromenes and terminal
alkynes . Org. Biomol. Chem. 
2018 , 16 , 5144 –5149 . 10.1039/C8OB00949J .29963678 
Zhu Z.-Q. ; Xiao L.-J. ; Chen Y. ; Xie Z.-B. ; Zhu H.-B. ; Le Z.-G. 
A highly efficient copper(II)-catalyzed cross-dehydrogenative-coupling
reaction of N-arylglycine esters with 2-arylimidazo[1,2-a]pyridines . Synthesis 
2018 , 50 , 2775 –2783 . 10.1055/s-0036-1609845 .
Li Y. ; Peng J. ; Chen X. ; Mo B. ; Li X. ; Sun P. ; Chen C. 
Copper-catalyzed synthesis of multisubstituted indoles
through tandem Ullmann-type C–N formation and cross-dehydrogenative
coupling reactions . J. Org. Chem. 
2018 , 83 , 5288 –5294 . 10.1021/acs.joc.8b00353 .29664297 
Doan S. H. ; Nguyen V. H. H. ; Nguyen T. H. ; Pham P. H. ; Nguyen N. N. ; Phan A. N. Q. ; Tu T. N. ; Phan N. T. S. 
Cross-dehydrogenative
coupling of coumarins with Csp3-H bonds using an iron–organic
framework as a productive heterogeneous catalyst . RSC Adv. 
2018 , 8 , 10736 –10745 . 10.1039/C8RA00872H .
Wang X. ; Lei B. ; Ma L. ; Zhu L. ; Zhang X. ; Zuo H. ; Zhuang D. ; Li Z. 
Cobalt-catalyzed
cross-dehydrogenative
C(sp2)-C(sp3) coupling of oxazole/thiazole with
ether or cycloalkane . Chem. Asian J. 
2017 , 12 , 2799 –2803 . 10.1002/asia.201701258 .28929591 
Zhu C. ; Zhu R. ; Zeng H. ; Chen F. ; Liu C. ; Wu W. ; Jiang H. 
Copper-catalyzed C(sp3)-H/C(sp3)-H cross-dehydrogenative
coupling with internal oxidants: synthesis of 2-trifluoromethyl-substituted
dihydropyrrol-2-ols . Angew. Chem., Int. Ed. 
2017 , 56 , 13324 –13328 . 10.1002/anie.201707719 .
Bityukov O. V. ; Matveeva O. K. ; Vil V. A. ; Kokorekin V. A. ; Nikishin G. I. ; Terent’ev A. O. 
Electrochemically induced intermolecular
cross-dehydrogenative C-O coupling of β-diketones and β-ketoesters
with carboxylic acids . J. Org. Chem. 
2019 , 84 , 1448 –1460 . 10.1021/acs.joc.8b02791 .30618255 
Xu X. ; Li P. ; Huang Y. ; Tong C. ; Yan Y. ; Xie Y. 
Atmospheric
oxidative catalyst-free cross-dehydrogenative coupling of aldehydes
with N-hydroxyimides . Tetrahedron
Lett. 
2017 , 58 , 1742 –1746 . 10.1016/j.tetlet.2017.03.064 .
Kramer S. 
Synthesis
of α-substituted primary benzylamines through copper-catalyzed
cross-dehydrogenative coupling . Org. Lett. 
2019 , 21 , 65 –69 . 10.1021/acs.orglett.8b03505 .30557025 
Wei W. ; Wang L. ; Bao P. ; Shao Y. ; Yue H. ; Yang D. ; Yang X. ; Zhao X. ; Wang H. 
Metal-free
C(sp2)-H/N-H cross-dehydrogenative coupling of quinoxalinones
with aliphatic amines under visible-light photoredox catalysis . Org. Lett. 
2018 , 20 , 7125 –7130 . 10.1021/acs.orglett.8b03079 .30372088 
Sun B. ; Yan Z. ; Jin C. ; Su W. 
(Diacetoxyiodo)benzene-mediated transition-metal-free
amination of C(sp3)-H bonds adjacent to heteroatoms with
azoles: synthesis of N-alkylated azoles . Synlett 
2018 , 29 , 2432 –2436 . 10.1055/s-0037-1610293 .
Kumar P. ; Kumar S. A. ; Singh R. ; Guntreddi T. ; Nand S. K. 
Nickel catalyzed ipso-hydroxylation and Subsequent
cross dehydrogenative coupling of arylboronic acids with tertiary
amines: A facile access to α-phenolated tertiary amines . Adv. Synth. Catal. 
2018 , 360 , 1786 –1789 . 10.1002/adsc.201701625 .
Ahmad A. ; Dutta H. S. ; Khan B. ; Kant R. ; Koley D. 
Cu(I)-Catalyzed
site selective acyloxylation of indoline using O2 as the
sole oxidant . Adv. Synth. Catal. 
2018 , 360 , 1644 –1649 . 10.1002/adsc.201800040 .
Rattanangkool E. ; Krailat W. ; Vilaivan T. ; Phuwapraisirisan P. ; Sukwattanasinitt M. ; Wacharasindhu S. 
Hypervalent iodine(III)-promoted
metal-free S–H activation: An approach for the construction
of S–S, S–N, and S–C bonds . Eur. J. Org. Chem. 
2014 , 2014 , 4795 –4804 . 10.1002/ejoc.201402180 .
Dou Y. ; Huang X. ; Wang H. ; Yang L. ; Li H. ; Yuan B. ; Yang G. 
Reusable cobalt-phthalocyanine in
water: Efficient catalytic aerobic oxidative coupling of thiols to
construct S–N/S–S bonds . Green
Chem. 
2017 , 19 , 2491 –2495 . 10.1039/C7GC00401J .
Huang X. ; Chen Y. ; Zhen S. ; Song L. ; Gao M. ; Zhang P. ; Li H. ; Yuan B. ; Yang G. 
Cobalt-catalyzed
aerobic cross-dehydrogenative coupling of C-H and thiols in water
for C-S formation . J. Org. Chem. 
2018 , 83 , 7331 –7340 . 10.1021/acs.joc.7b02718 .29313345 
Yang D. ; Sun P. ; Wei W. ; Meng L. ; He L. ; Fang B. ; Jiang W. ; Wang H. 
Metal-free iodine-catalyzed
direct
cross-dehydrogenative coupling (CDC) between pyrazoles and thiols . Org. Chem. Front. 
2016 , 3 , 1457 –1461 . 10.1039/C6QO00407E .
Chang C.-Z. ; Liu X. ; Zhu H. ; Wu L. ; Dong Z.-B. 
Copper-catalyzed
and air-mediated mild cross-dehydrogenative coupling of aryl thioureas
and dialkyl H-phosphonates: The synthesis of thiophosphonates . J. Org. Chem. 
2018 , 83 , 13530 –13535 . 10.1021/acs.joc.8b02011 .30354124 
Liu Y. ; Liu Z. ; Zhang Y. ; Xiong C. 
Manganese(III) acetylacetonate-mediated
phosphorylation of enamides at room temperature . Adv. Synth. Catal. 
2018 , 360 , 3492 –3496 . 10.1002/adsc.201800585 .
Deng L. ; Wang Y. ; Mei H. ; Pan Y. ; Han J. 
Electrochemical
dehydrogenative phosphorylation of alcohols for the synthesis of organophosphinates . J. Org. Chem. 
2019 , 84 , 949 –956 . 10.1021/acs.joc.8b02882 .30608670 
Song G. ; Li X. 
Substrate activation
strategies in rhodium (III)-catalyzed selective
functionalization of arenes . Acc. Chem. Res. 
2015 , 48 , 1007 –1020 . 10.1021/acs.accounts.5b00077 .25844661 
Yang Y. ; Lan J. ; You J. 
Oxidative
C–H/C–H coupling reactions
between two (hetero) arenes . Chem. Rev. 
2017 , 117 , 8787 –8863 . 10.1021/acs.chemrev.6b00567 .28085272 
a Perepichka I. ; Kundu S. ; Hearne Z. ; Li C.-J. 
Efficient merging of copper and photoredox
catalysis for the asymmetric
cross-dehydrogenativecoupling of alkynes and tetrahydroisoquinolines . Org. Biomol. Chem. 
2015 , 13 , 447 –451 . 10.1039/C4OB02138J .25372475  b Wang F.-F. ; Luo C.-P. ; Deng G. ; Yang L. 
C(sp3)–C(sp3) bond formation via copper/Brønsted
acid co-catalyzed C(sp3)–H bond oxidative cross-dehydrogenative-coupling
(CDC) of azaarenes . Green Chem. 
2014 , 16 , 2428 –2431 . 10.1039/c4gc00038b . c Liu X. ; Zhang J. ; Ma S. ; Ma Y. ; Wang R. 
Oxidative
cross-dehydrogenative coupling between N-aryl tetrahydroisoquinolins
and 5H-oxazol-4-ones through two methodologies: copper catalysis or
a metal-free strategy . Chem. Commun. 
2014 , 50 , 15714 –15717 . 10.1039/C4CC04508D .
Xuan J. ; Zeng T.-T. ; Feng Z.-J. ; Deng Q.-H. ; Chen J.-R. ; Lu L.-Q. ; Xiao W.-J. ; Alper H. 
Redox-neutral α-allylation
of amines by combining palladium catalysis and visible-light photoredox
catalysis . Angew. Chem., Int. Ed. 
2015 , 54 , 1625 –1628 . 10.1002/anie.201409999 .
Xie J. ; Li H. ; Zhou J. ; Cheng Y. ; Zhu C. 
A highly efficient
gold-catalyzed oxidative C–C coupling from C–H bonds
using air as oxidant . Angew. Chem., Int. Ed. 
2012 , 51 , 1252 –1255 . 10.1002/anie.201107605 .
Meng Q.-Y. ; Liu Q. ; Zhong J.-J. ; Zhang H.-H. ; Li Z.-J. ; Chen B. ; Tung C.-H. ; Wu L. Z. 
Graphene-supported
RuO2 nanoparticles for efficient aerobic cross-dehydrogenative
coupling
reaction in water . Org. Lett. 
2012 , 14 , 5992 –5995 . 10.1021/ol3028785 .23194402 
a Yu J.-B. ; Zhang Y. ; Jiang Z.-J. ; Su W.-K. 
Mechanically induced Fe(III) catalysis at room temperature: solvent-free
cross-dehydrogenative coupling of 3-benzylic indoles with methylenes/indoles . J. Org. Chem. 
2016 , 81 , 11514 –11520 . 10.1021/acs.joc.6b02197 .27779398  b Ratnikov M. O. ; Xu X. ; Doyle M. P. 
Simple and sustainable iron-catalyzed aerobic C–H
functionalization of N,N-dialkylanilines . J. Am. Chem. Soc. 
2013 , 135 , 9475 –9479 . 10.1021/ja402479r .23734676 
a Condie A. G. ; Gozález-Gómez J. C. ; Stephenson C. R. J. 
Visible-light
photoredox catalysis: aza-Henry reactions
via C–H functionalization . J. Am. Chem.
Soc. 
2010 , 132 , 1464 –1465 . 10.1021/ja909145y .20070079  b Feng Z.-J. ; Xuan J. ; Xia X.-D. ; Ding W. ; Guo W. ; Chen J.-R. ; Zou Y.-Q. ; Lu L.-Q. ; Xiao W.-J. 
Direct
sp3 C-H acroleination of N-aryltetrahydroisoquinolines
by merging photoredox catalysis with nucleophilic catalysis . Org. Biomol. Chem. 
2014 , 12 , 2037 –2040 . 10.1039/C3OB42453G .24553793 
Jones K. M. ; Karier P. ; Klussmann M. 
C1-Substituted N-alkyl tetrahydroisoquinoline derivatives through V-catalyzed
oxidative
coupling . ChemCatChem 
2012 , 4 , 51 –54 . 10.1002/cctc.201100324 .
Li Q. ; Hu W. ; Hu R. ; Lu H. ; Li G. 
Cobalt-catalyzed cross-dehydrogenative
coupling reaction between unactivated C(sp2)-H and C(sp3)-H bonds . Org. Lett. 
2017 , 19 , 4676 –4679 . 10.1021/acs.orglett.7b02316 .28829611 
Majji G. ; Guin S. ; Rout S. K. ; Behera A. ; Patel B. K. 
Cyclic
ethers to esters and monoesters to bis-esters with unconventional
coupling partners under metal free conditions via sp3 C–H
functionalization . Chem. Commun. 
2014 , 50 , 12193 –12196 . 10.1039/C4CC05050A .
a Pan Y. ; Wang S. ; Kee C. W. ; Dubuisson E. ; Yang Y. ; Loh K. P. ; Tan C.-H. 
Graphene
oxide and rose bengal: oxidative C–H functionalisation of tertiary
amines using visible light . Green Chem. 
2011 , 13 , 3341 –3344 . 10.1039/c1gc15865a . b Zhong J.-J. ; Meng Q.-Y. ; Liu B. ; Li X.-B. ; Gao X.-W. ; Lei T. ; Wu C.-J. ; Li Z.-J. ; Tung C.-H. ; Wu L.-Z. 
Cross-coupling hydrogen evolution
reaction in homogeneous solution without noble metals . Org. Lett. 
2014 , 16 , 1988 –1991 . 10.1021/ol500534w .24628016 
Franz J. F. ; Kraus W. B. ; Zeitler K. 
No photocatalyst
required-versatile,
visible light mediated transformations with polyhalomethanes . Chem. Commun. 
2015 , 51 , 8280 –8283 . 10.1039/C4CC10270C .
Huang L. ; Zhao J. 
Iodo-Bodipys as visible-light-absorbing
dual-functional photoredox
catalysts for preparation of highly functionalized organic compounds
by formation of C–C bonds via reductive and oxidative quenching
catalytic mechanisms . RSC Adv. 
2013 , 3 , 23377 –23388 . 10.1039/c3ra43299h .
Liu Q. ; Li Y.-N. ; Zhang H.-H. ; Chen B. ; Tung C.-H. ; Wu L.-Z. 
Reactivity and mechanistic insight into visible-light-induced aerobic
cross-dehydrogenative coupling reaction by organophotocatalysts . Chem. – Eur. J. 
2012 , 18 , 620 –627 . 10.1002/chem.201102299 .22162148 
Behbehani H. ; Ibrahim H. M. 
A strategy for the
synthesis of 2-aryl-3-dimethylamino-
pyrazolo[3,4-c]pyridines that utilizes [4+1] cycloaddition
reactions of 5-arylazo-2,3,6-trisubstituted pyridines . Tetrahedron 
2013 , 69 , 10535 –10543 . 10.1016/j.tet.2013.10.061 .
Behbehani H. ; Ibrahim H. M. ; Makhseed S. ; Elnagdi M. H. ; Mahmoud H. 
2-Aminothiophenes
as Building Blocks in Heterocyclic Synthesis: Synthesis and Antimicrobial
Evaluation of a New Class of Pyrido[1,2-a]thieno[3,2-e]pyrimidine, quinoline and Pyridin-2-one Derivatives . Eur. J. Med. Chem. 
2012 , 52 , 51 –65 . 10.1016/j.ejmech.2012.03.004 .22464424 
Ibrahim H. M. ; Arafa W. A. A. ; Behbehani H. 
L-Proline
catalyzed one-pot synthesis
of polysubstituted pyridine system incorporating benzothiazole moiety
via sustainable sonochemical approach . RSC Adv. 
2018 , 8 , 37606 –37617 . 10.1039/C8RA07013J .
Behbehani H. ; Ibrahim H. M. ; Elnagdi M. H. 
Non-concerted nucleophilic [4+1]
cycloaddition of (dimethylamino)methoxycarbene to arylazonicotinates
in the synthesis of a pyrazolo[3,4-c]pyridines and
pyrazolo[4′,3′:4,5]pyrido[2,3-d]pyrimidines . Tetrahedron 
2013 , 69 , 6176 –6184 . 10.1016/j.tet.2013.05.040 .
Behbehani H. ; Ibrahim H. M. 
Microwave assisted
synthesis in water. First one pot
synthesis of a novel class of polysubstituted benzo[4,5]imidazo[1,2-b]pyridazines
via intramolecular SNAr . RSC Adv. 
2015 , 5 , 89226 –89237 . 10.1039/C5RA17313B .
Behbehani H. ; Ibrahim H. M. 
An efficient ultrasonic-mediated one-pot synthesis
of 2,3,6,7,9- pentaazabicyclo- [3.3.1]nonanes via a N,N-dimethylformamide dimethylacetal catalyzed Mannich-like
reaction . RSC Adv. 
2016 , 6 , 52700 –52709 . 10.1039/C6RA09210A .
a Koike T. ; Takai T. ; Hoashi Y. ; Nakayama M. ; Kosugi Y. ; Nakashima M. ; Yoshikubo S. ; Hirai K. ; Uchikawa O. 
Synthesis of a novel
series of tricyclic dihydrofuran derivatives: discovery of 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as melatonin
receptor (MT1/MT2) ligands . J. Med. Chem. 
2011 , 54 , 4207 –4218 . 10.1021/jm200385u .21568291  b Mousseau J. J. ; Bull J. A. ; Ladd C. L. ; Fortier A. ; Roman D. S. ; Charette A. B. 
Synthesis of 2- and 2,3-substituted
pyrazolo[1,5-a]pyridines: scope and mechanistic considerations
of a domino direct alkynylation and cyclization of N-iminopyridinium ylides using alkenyl bromides, alkenyl iodides,
and alkynes . J. Org. Chem. 
2011 , 76 , 8243 –8261 . 10.1021/jo201303x .21902233  c Elsner J. ; Boeckler F. ; Davidson K. ; Sugden D. ; Gmeiner P. 
Bicyclic melatonin
receptor agonists containing a ring-junction nitrogen: Synthesis,
biological evaluation, and molecular modeling of the putative bioactive
conformation . Bioorg. Med. Chem. 
2006 , 14 , 1949 –1958 . 10.1016/j.bmc.2005.10.042 .16290939  d Ibrahim H. M. ; Behbehani H. ; Mostafa N. S. 
Scalable sonochemical
synthetic strategy for pyrazolo[1,5-a]pyridine derivatives:
First catalyst free concerted [3+2] cycloaddition of alkyne and alkene
derivatives to 2-imino-1H-pyridin-1-amines . ACS Omega 
2019 , 4 , 7182 –7193 . 10.1021/acsomega.9b00562 .31459824  e Yu X. ; Ye S. ; Wu J. 
Facile assembly of
H-pyrazolo[5,1,a]isoquinolines via silver triflate-catalyzed
one-pot tandem reaction of 2-alkynyl-benzaldehyde, sulfonohydrazide,
and ketone or aldehyde . Adv. Synth. Catal. 
2010 , 352 , 2050 –2056 . 10.1002/adsc.201000176 .
Chen Z. ; Wu J. 
Efficient generation of biologically
active H-Pyrazolo[5,1-a] isoquinolines via multicomponent
reaction . Org. Lett. 
2010 , 12 , 4856 –4859 . 10.1021/ol101988q .20873765 
Johns B. A. ; Gudmundsson K. S. ; Turner E. M. ; Allen S. H. ; Jung D. K. ; Sexton C. J. ; Boyd F. L. ; Peel M. R. 
Pyrazolo[1,5-a]pyridines:
synthetic approaches to a novel class of antiherpetics . Tetrahedron 
2003 , 59 , 9001 –9011 . 10.1016/j.tet.2003.02.003 .
Hoashi Y. ; Takai T. ; Kotani E. ; Koike T. 
Synthesis of pyrazolo[1,5-a]pyridines by thermal
intramolecular cyclization . Tetrahedron Lett. 
2013 , 54 , 2199 –2202 . 10.1016/j.tetlet.2013.02.078 .
a Abramovitch R. A. ; Kalinowski J. 
Pyrido[1,2-b] indazole and its derivatives . J.
Heterocycl. Chem. 
1974 , 11 , 857 –861 . 10.1002/jhet.5570110603 . b Abramovitch R. A. ; Adams K. A. H. 
Tryptamines,
carbolines, and related compounds: part ix. the cyclization of some
nitro- and azido-phenylpyridines. pyrido[1,2-b]indazole . Can. J. Chem. 
1961 , 39 , 2516 –2528 . 10.1139/v61-332 . c Abramovitch R. A. ; Ahmad Y. ; Newman D. 
The formation of a nitrene intermediate in the reaction
of nitro compounds with ferrous oxalate . Tetrahedron
Lett. 
1961 , 2 , 752 –757 . 10.1016/S0040-4039(01)99261-5 . d Zhao J. ; Wu C. ; Li P. ; Ai W. ; Chen H. ; Wang C. ; Larock R. C. ; Shi F. 
Synthesis
of pyrido[1,2-b]indazoles via aryne [3 + 2] cycloaddition with n-tosylpyridinium
imides . J. Org. Chem. 
2011 , 76 , 6837 –6843 . 10.1021/jo200863e .21755977 
Ibrahim H. M. ; Behbehani H. 
Sustainable synthetic approach for (pyrazol-4-ylidene)pyridines
by metal catalyst-free aerobic C(sp2)–C(sp3) coupling reactions
between 1-amino-2-imino-pyridines and 1-aryl-5-pyrazolones . ACS Omega 
2019 , 4 , 11701 –11711 . 10.1021/acsomega.9b01650 .31460276 
Sheldrick G. M. 
A short
history of SHELX . Acta Crystallogr., Sect. A:
Found. Crystallogr. 
2008 , 64 , 112 –122 . 10.1107/S0108767307043930 .
Schmidpeter A. ; Steinmüller F. ; Zabotina E. Y. 
Four and fivemembered phosphorus
heterocycles. LXXXIV. [1,5]-anellated 1,2,4,3-triazaphospholes . J. Prakt. Chem. A. 
1993 , 335 , 458 –460 . 10.1002/prac.19933350512 .
The crystallographic data
for 4i (ref. CCDC 1916934), 4r (ref. CCDC
1940357), 6a (ref. CCDC 1916935), 6c (ref.
CCDC 1916936),
and 6d (ref. CCDC 1916937) can be obtained on request
from the director, Cambridge Crystallographic Data Center, 12 Union
Road, Cambridge CB2 1EW, U.K.

